V-Bio Ventures — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.
AgTechBiotechDeep TechHealthtechGhent, BE
Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in
Co-investorsAgri Investment FundSeventure PartnersPMVQbic FundAIFVIB
Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications.
BiotechMedical DevicesMontpellier, FR
Develops electric weed control technology using high-frequency AC to destroy weeds to the roots, as an alternative to chemical herbicides.
Co-investorsAgri Investment FundOxford Investment Opportunity Network (OION)Rabo Corporate VenturingThe Yield Lab EuropePymwymicThe Yield Lab
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











